rhodamine 123 has been researched along with Hormone-Dependent Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, LW; Narayan, KS; Shapiro, CE; Sweatman, TW | 1 |
| Alken, P; Köhrmann, KU; Kreukler, C; Nebe, T; Siegsmund, MJ; Steidler, A | 1 |
| Arcadi, JA | 1 |
1 trial(s) available for rhodamine 123 and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Rhodamine-123: therapy for hormone refractory prostate cancer, a phase I clinical trial.
Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms; Rhodamine 123; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
2 other study(ies) available for rhodamine 123 and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.
Topics: Androgens; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorescent Dyes; Genes, MDR; Male; Methotrexate; Neoplasms, Hormone-Dependent; Paclitaxel; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1997 |
Use of rhodamine 123 in the treatment of the Pollard III rat prostate adenocarcinoma.
Topics: Adenocarcinoma; Androgens; Animals; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Xanthenes | 1990 |